Noridian publishes review results

 - 
Tuesday, July 7, 2015

FARGO, N.D. – Noridian Healthcare Solutions, the Jurisdiction D DME MAC, has published the results of prepayment reviews for a number of products. Oxygen (E1390) had a potential improper payment rate of 31% from March 2015 through May 2015. Group 2 pressure reducing support surfaces (E0277) had a potential improper payment rate of 62% from February 2015 though May 2015, while Group 1 pressure reducing support surfaces (E0181 and E0185) had improper rates of 52% and 63%, respectively, during that same timeframe. Vacuum erection devices (L7900) had a potential improper payment rate of 97% from February 2015 through May 2015. Diabetes testing supplies (A4253 and A4253KX) had improper rates of 50% and 64%, respectively, from March 2015 through May 2015.

Tags: